Why NuVasive Stock Skyrocketed 56.1% in 2019
Thanks to market-beating revenue growth and optimism surrounding its next-generation spine surgery platform, NuVasive (NASDAQ: NUVA) was a top-performing healthcare company last year, returning a market-leading 56.1% in 2019, according to S&P Global Market Intelligence.
NuVasive's minimally invasive lateral surgical systems are a compelling alternative to traditional systems that access the spine through the back or front of the body. By allowing surgeons to access the spine through a patient's side, recovery times can be shorter and there are potentially fewer complications.
Image source: Getty Images.
Source Fool.com
